Cargando…
Advances in RIPK1 kinase inhibitors
Programmed necrosis is a new modulated cell death mode with necrotizing morphological characteristics. Receptor interacting protein 1 (RIPK1) is a critical mediator of the programmed necrosis pathway that is involved in stroke, myocardial infarction, fatal systemic inflammatory response syndrome, Al...
Autores principales: | Chen, Lu, Zhang, Xiaoqin, Ou, Yaqing, Liu, Maoyu, Yu, Dongke, Song, Zhiheng, Niu, Lihong, Zhang, Lijuan, Shi, Jianyou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554302/ https://www.ncbi.nlm.nih.gov/pubmed/36249746 http://dx.doi.org/10.3389/fphar.2022.976435 |
Ejemplares similares
-
Erratum: Advances in RIPK1 kinase inhibitors
Publicado: (2023) -
Research advances in drug therapy of endometriosis
por: Shi, Jianyou, et al.
Publicado: (2023) -
Corrigendum: Research advances in drug therapy of endometriosis
por: Shi, Jianyou, et al.
Publicado: (2023) -
Corrigendum: Research advances in drug therapy of endometriosis
por: Shi, Jianyou, et al.
Publicado: (2023) -
Discovery and development of Factor Xa inhibitors (2015–2022)
por: Zheng, Wei, et al.
Publicado: (2023)